Amdocs Ltd. (DOX) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Amdocs’s revenue went from $3.7B in fiscal 2016 to $4.5B in fiscal 2025, growth of about 2.2% a year.
Net income in fiscal 2025 was $554M, a net margin of 12.2%; the best year in this period was 2021 with $688M.
Over the twelve months to September 30, 2026, revenue was $4.7B and net income $497M.
Free cash flow was $645M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 4% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.7B | $4.5B | $5.0B | $4.9B | $4.6B | $4.3B | $4.2B | $4.1B | $4.0B | $3.9B | $3.7B |
| Gross profit | — | — | $1.8B | $1.7B | $1.6B | $1.5B | $1.4B | $1.4B | $1.4B | $1.4B | $1.3B |
| Operating income | — | — | $629M | $654M | $665M | $599M | $595M | $570M | $428M | $517M | $483M |
| Net income | $497M | $554M | $493M | $541M | $550M | $688M | $498M | $479M | $354M | $437M | $409M |
| EPS (diluted) | $4.68 | $4.96 | $4.57 | $5.01 | $5.09 | $6.38 | $4.61 | $4.44 | $3.28 | $4.05 | $3.79 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | −9.4% | +2.4% | +6.8% | +6.7% | +2.9% | +2.0% | +2.8% | +2.8% | +4.0% | +2.1% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $673M | $749M | $724M | $823M | $757M | $926M | $658M | $656M | $557M | $636M | $620M |
| Capital spending | -$111M | -$104M | -$105M | -$124M | -$227M | -$210M | -$206M | -$128M | -$231M | -$133M | -$130M |
| Free cash flow | $562M | $645M | $619M | $698M | $530M | $715M | $453M | $528M | $326M | $503M | $490M |
| Dividends paid | $234M | $224M | $212M | $199M | $186M | $177M | $164M | $148M | $134M | $122M | $109M |
| Buybacks | — | — | $563M | $490M | $508M | $680M | $361M | $398M | $419M | $341M | $413M |
| Stock-based pay | — | — | $105M | $90M | $72M | $54M | $42M | $39M | $47M | $45M | $43M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $514M | $514M | $743M | $818M | $966M | $984M | $472M | $519M | $980M | $1.1B |
| Debt | — | $790M | $790M | $807M | $827M | $881M | $1.0B | — | — | — | $200M |
| Equity | — | $3.5B | $3.5B | $3.5B | $3.5B | $3.6B | $3.6B | $3.5B | $3.4B | $3.6B | $3.5B |
| Total assets | — | $6.4B | $6.4B | $6.4B | $6.4B | $6.5B | $6.3B | $5.3B | $5.3B | $5.3B | $5.3B |
| Shares (diluted) | 106M | 112M | 108M | 108M | 108M | 108M | 108M | 108M | 108M | 108M | 108M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 35.1% | 35.4% | 35.4% | 34.5% | 33.9% | 35.1% | 34.7% | 35.2% | 35.2% |
| Operating margin | — | — | 12.6% | 13.4% | 14.5% | 14.0% | 14.3% | 13.9% | 10.8% | 13.4% | 13.0% |
| Net margin | 10.6% | 12.2% | 9.8% | 11.1% | 12.0% | 16.1% | 11.9% | 11.7% | 8.9% | 11.3% | 11.0% |
| FCF margin | 12.0% | 14.2% | 12.4% | 14.3% | 11.6% | 16.7% | 10.9% | 12.9% | 8.2% | 13.0% | 13.2% |
| ROIC | — | — | 12.4% | 12.9% | 13.0% | 11.3% | 10.9% | 13.7% | 10.4% | 12.3% | 11.2% |
| ROE | — | — | 14.3% | 15.3% | 15.6% | 19.2% | 13.7% | 13.7% | 10.3% | 12.2% | 11.8% |
Frequently asked questions
What is Amdocs’s annual revenue?
$4.5B in fiscal 2025 and $4.7B over the twelve months to September 30, 2026.
How much profit does Amdocs make?
Net income was $554M in fiscal 2025 (net margin 12.2%).
Is Amdocs’s revenue growing?
No: revenue fell 9.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.